Cite
HARVARD Citation
Manzaneque, A. et al. (n.d.). DI-010 Factors influencing the appearance of haematological and thyroid adverse effects in patients with hepatitis C virus genotype 1 treated with telaprevir/boceprevir plus peg-interferon and ribavirin. European journal of hospital pharmacy. p. A79. [Online].